Holen Sie sich die Stockscreener-App
12.15
4.56%
-0.58
Schlusskurs vom Vortag:
$12.73
Offen:
$12.72
24-Stunden-Volumen:
769.89K
Relative Volume:
0.49
Marktkapitalisierung:
$1.36B
Einnahmen:
$577.74M
Nettoeinkommen (Verlust:
$-149.78M
KGV:
-8.6786
EPS:
-1.4
Netto-Cashflow:
$-78.21M
1W Leistung:
-1.06%
1M Leistung:
+7.14%
6M Leistung:
-41.08%
1J Leistung:
-29.89%
1-Tages-Spanne:
$12.15
$12.76
1-Wochen-Bereich:
$11.98
$13.67
52-Wochen-Spanne:
$10.87
$34.13
Novocure Ltd Stock (NVCR) Company Profile
Firmenname
Novocure Ltd
Sektor
Branche
Telefon
44 (0)15 3475 6700
Adresse
NO. 4 THE FORUM, ST. HELIER
Vergleichen Sie NVCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVCR
Novocure Ltd
|
12.15 | 1.37B | 577.74M | -149.78M | -78.21M | -1.40 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Novocure Ltd Stock (NVCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-12-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-10-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-08-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-08-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | Eingeleitet | SVB Securities | Outperform |
| 2023-07-31 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2023-06-07 | Hochstufung | Wedbush | Underperform → Neutral |
| 2023-05-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-01-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-05 | Bestätigt | H.C. Wainwright | Buy |
| 2022-11-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-07-05 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2022-05-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-02-08 | Eingeleitet | Loop Capital | Buy |
| 2022-02-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-20 | Hochstufung | Truist | Hold → Buy |
| 2022-01-03 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-07-01 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-04-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-01-25 | Bestätigt | Piper Sandler | Overweight |
| 2020-09-23 | Eingeleitet | Northland Capital | Outperform |
| 2020-09-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-09-17 | Herabstufung | Truist | Buy → Hold |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Perform |
| 2020-05-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-07-29 | Hochstufung | SunTrust | Hold → Buy |
| 2019-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2018-11-02 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-07-16 | Eingeleitet | Evercore ISI | Outperform |
| 2018-04-18 | Bestätigt | Mizuho | Buy |
| 2018-02-23 | Bestätigt | Mizuho | Buy |
| 2017-05-24 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-07-29 | Bestätigt | Wedbush | Outperform |
| 2016-01-19 | Eingeleitet | Barclays | Underweight |
| 2015-12-02 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Novocure Ltd Aktie (NVCR) Neueste Nachrichten
Teza Capital Management LLC Cuts Holdings in NovoCure Limited $NVCR - MarketBeat
Cinctive Capital Management LP Lowers Stake in NovoCure Limited $NVCR - MarketBeat
Cubist Systematic Strategies LLC Sells 83,600 Shares of NovoCure Limited $NVCR - MarketBeat
NovoCure Limited $NVCR Shares Sold by Hsbc Holdings PLC - MarketBeat
Graham Capital Management L.P. Grows Stock Holdings in NovoCure Limited $NVCR - MarketBeat
Novocure at Morgan Stanley Healthcare Conference: Expanding Cancer Treatment Horizons - Investing.com
NovoCure (NASDAQ:NVCR) Shares Gap Up After Insider Buying Activity - MarketBeat
Ashley Cordova Acquires 81,550 Shares of NovoCure (NASDAQ:NVCR) Stock - MarketBeat
NovoCure (NVCR): Evaluating Valuation After FDA Approval of Optune Lua and Shifts in Investor Positioning - simplywall.st
70,795 Shares in NovoCure Limited $NVCR Purchased by American Century Companies Inc. - MarketBeat
Is NovoCure Limited a turnaround storyMarket Activity Report & Community Trade Idea Sharing Platform - Lancaster City Council
Novocure at H.C. Wainwright: Strategic Growth in Cancer Treatment - Investing.com
What earnings revisions data tells us about NovoCure Limited2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Will NovoCure Limited see short term momentumJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser
NovoCure Limited $NVCR Shares Sold by Panagora Asset Management Inc. - MarketBeat
What to expect from NovoCure Limited in the next 30 daysWeekly Trend Report & Safe Capital Growth Plans - Newser
Hedge Fund and Insider Trading News: Ken Griffin, Steve Cohen, Anthony Scaramucci, Bill Ackman, Marshall Wace, Point72 Asset Management, Third Point, Brevan Howard, Audioeye Inc (AEYE), NovoCure Ltd (NVCR), and More - Insider Monkey
Top chart patterns to watch in NovoCure LimitedMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
NovoCure Limited Stock (NVCR) Opinions on FDA Approval of Optune Lua Device - Quiver Quantitative
Novocure CEO Cordova buys shares worth $996k By Investing.com - Investing.com South Africa
Novocure CEO Cordova buys shares worth $996k - Investing.com India
How to monitor NovoCure Limited with trend dashboards2025 Institutional Moves & Weekly High Potential Alerts - Newser
Novocure announces coverage for Tumor Treating Fields therapy in Spain - MSN
Will NovoCure Limited continue its uptrend2025 Fundamental Recap & Daily Stock Momentum Reports - Newser
NovoCure Limited $NVCR Shares Purchased by Palo Alto Investors LP - MarketBeat
Can NovoCure Limited continue delivering strong returnsJuly 2025 Rallies & Reliable Entry Point Trade Alerts - خودرو بانک
Is NovoCure Limited stock undervalued right nowPortfolio Performance Report & Capital Efficiency Focused Ideas - خودرو بانک
Loss Report: Can NovoCure Limited deliver consistent dividendsShare Buyback & Expert Verified Stock Movement Alerts - خودرو بانک
What machine learning models say about NovoCure Limited2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
How to build a dashboard for NovoCure Limited stockRate Hike & Daily Stock Trend Reports - Newser
Northern Trust Corp Has $22.02 Million Stock Holdings in NovoCure Limited $NVCR - MarketBeat
Novocure at Wells Fargo Conference: Expanding Cancer Treatment Horizons - Investing.com
Is NovoCure Limited exposed to currency risks2025 Market WrapUp & Weekly Top Gainers Trade List - خودرو بانک
American Century Companies Inc. Invests $1.26 Million in NovoCure Limited $NVCR - Defense World
Strategies to average down on NovoCure LimitedJuly 2025 Outlook & Technical Pattern Based Buy Signals - Newser
Does NovoCure Limited show high probability of reboundEarnings Growth Summary & Consistent Return Strategy Ideas - Newser
Can NovoCure Limited recover in the next quarterTrend Reversal & Verified Technical Signals - Newser
What the charts say about NovoCure Limited today2025 AllTime Highs & Low Drawdown Investment Ideas - Newser
Understanding NovoCure Limited’s price movementWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Is NovoCure Limited a top pick in the sectorJuly 2025 Summary & Daily Chart Pattern Signals - خودرو بانک
Invesco Ltd. Lowers Stake in NovoCure Limited $NVCR - Defense World
NovoCure (NVCR) Is Up 5.4% After Spain Reimburses TTFields Therapy—Has The Bull Case Changed? - Yahoo Finance
Can NovoCure Limited generate free cash flowJuly 2025 Reactions & Community Driven Trade Alerts - خودرو بانک
Is NovoCure Limited stock entering bullish territoryGap Up & Verified Entry Point Signals - Newser
How to forecast NovoCure Limited trends using time series2025 Market WrapUp & Stock Timing and Entry Methods - Newser
NovoCure Limited stock momentum explainedDip Buying & Reliable Entry Point Alerts - Newser
Identifying reversal signals in NovoCure LimitedTrade Volume Summary & Long-Term Growth Portfolio Plans - Newser
Price momentum metrics for NovoCure Limited explainedGap Down & Detailed Earnings Play Alerts - Newser
RSI Suggests Rebound May Be Near in NovoCure Limited getLinesFromResByArray error: size == 0 - 더경남뉴스
Nationwide Spanish Reimbursement for TTFields Could Be a Game Changer for NovoCure (NVCR) - simplywall.st
NovoCure Limited stock chart pattern explainedQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Finanzdaten der Novocure Ltd-Aktie (NVCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novocure Ltd-Aktie (NVCR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brackmann Christoph | Chief Financial Officer |
Jul 29 '25 |
Buy |
11.59 |
20,000 |
231,800 |
141,150 |
| Stafford Kristin | Director |
Jun 03 '25 |
Sale |
17.28 |
999 |
17,259 |
3,054 |
| LEUNG GABRIEL | Director |
Jun 03 '25 |
Sale |
17.31 |
999 |
17,297 |
81,229 |
| Madden Martin J. | Director |
Jun 03 '25 |
Sale |
17.19 |
999 |
17,176 |
18,674 |
| Scannell Timothy J | Director |
Jun 03 '25 |
Sale |
17.32 |
999 |
17,299 |
6,018 |
| HILLEMAN JERYL L | Director |
Jun 03 '25 |
Sale |
17.26 |
999 |
17,247 |
5,591 |
| Ocean Allyson J | Director |
Jun 03 '25 |
Sale |
17.29 |
999 |
17,269 |
3,054 |
| VERNON W ANTHONY | Director |
Jun 03 '25 |
Sale |
17.35 |
999 |
17,329 |
167,887 |
| Hung David | Director |
Jun 03 '25 |
Sale |
17.30 |
999 |
17,280 |
12,195 |
| Leonard Frank X | EVP, Pres., Novocure Oncology |
Jun 02 '25 |
Sale |
17.50 |
30,196 |
528,413 |
168,452 |
1.14%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):